Other formats:
BibTeX
LaTeX
RIS
@article{1479522, author = {Heissigerová, Jarmila and Callanan, David and de Smet, Marc and Srivastava, Sunil K. and Karkanová, Michala and GarciaandGarcia, Olga and Kadayifcilar, Sibel}, doi = {http://dx.doi.org/10.1016/j.ophtha.2018.09.044}, keywords = {Sarilumab, rear uveitis, anti-interleukin-6 receptor antibody}, language = {eng}, issn = {0161-6420}, journal = {Ophthalmology}, title = {Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial}, url = {http://dx.doi.org/10.1016/j.ophtha.2018.09.044}, year = {2019} }
TY - JOUR ID - 1479522 AU - Heissigerová, Jarmila - Callanan, David - de Smet, Marc - Srivastava, Sunil K. - Karkanová, Michala - Garcia-Garcia, Olga - Kadayifcilar, Sibel PY - 2019 TI - Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial JF - Ophthalmology SP - 1549-4713 EP - 1549-4713 SN - 01616420 KW - Sarilumab, rear uveitis, anti-interleukin-6 receptor antibody UR - http://dx.doi.org/10.1016/j.ophtha.2018.09.044 L2 - http://dx.doi.org/10.1016/j.ophtha.2018.09.044 N2 - To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).Subcutaneous sarilumab may provide clinical benefits in the management of NIU of the posterior segment, especially in eyes with uveitic macular edema. ER -
HEISSIGEROVÁ, Jarmila, David CALLANAN, Marc DE SMET, Sunil K. SRIVASTAVA, Michala KARKANOVÁ, Olga GARCIA-GARCIA and Sibel KADAYIFCILAR. Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial. \textit{Ophthalmology}. 2019, p.~1549-4713. ISSN~0161-6420. Available from: https://dx.doi.org/10.1016/j.ophtha.2018.09.044.
|